JBSS Heads Into Earnings With Short Sellers Cautiously Positioned

John B. Sanfilippo & Son reports first-quarter results today with short sellers holding a modest but meaningful stake, and the borrow market far too loose to suggest any squeeze dynamic is building. Short interest runs at 6.2% of the free float, roughly 560,000 shares, down about 2% on the week but up 8% over the past month. Borrowing costs remain negligible at 0.26%, and availability is extremely loose at over 3,600%, meaning shares to borrow are plentiful relative to current short positions. Options traders are also calm: the put/call ratio of 0.28 sits barely above its 20-day average and well below anything that would flag defensive positioning. The stock itself has drifted lower, closing at $66.34, off about 1.3% over the past month, and down 1.1% on the final session before the print.

The bull-versus-bear debate heading into today centres on the product recall that hit the fiscal fourth quarter. Bears point to the recall tied to dry milk powder used in certain products, which created an estimated $2.5 million impact and flagged potential vulnerabilities in quality control and supply-chain management. For a single-segment company, that kind of one-off hits margins hard and invites questions about whether normalisation is complete. Bulls counter that a large contract manufacturing customer helped cushion the blow in that quarter, and that new production equipment coming online to support protein bar manufacturing represents a genuine growth driver. The nut-snack and protein-bar categories align with broader consumer trends, and BWS Financial has maintained a Buy rating with a $109 price target through the most recent analyst action in September, though the stock at $66.34 sits well below that level.

Analyst coverage is thin. Freedom Broker upgraded JBSS to Buy in August while trimming its target to $91, and BWS Financial has held its Buy and $109 target unchanged through multiple reiterations. The consensus register shows only one Hold alongside these Buys, and the mean target of $102 implies meaningful upside from current levels. That gap between targets and price reflects a stock that has lagged its sector peers badly. General Mills, Conagra and Campbell's each posted weekly gains above 16% in a recent sector rotation, while JBSS's year-to-date advance has been a modest 4%.

The family's grip on the register remains firm. Sanfilippo family members collectively hold shares representing roughly 20% of the company across multiple trusts and individual stakes, and that concentration has been stable. BlackRock holds about 12.8% as the largest institutional investor, adding around 77,000 shares in the most recent reported quarter.

Today's print is less about whether the nut business is fundamentally intact and more about whether the recall's gross margin impact has fully washed through, and whether the protein bar equipment ramp is materialising fast enough to offset volume softness in the core business.